Resources
Alberta pharmacies
Reference Guide for the 2023-2024 Alberta Influenza Immunization Program
AlbertaQuits Pharmacy Claims Reference Guide
Critical Supply Product List (PDF) | (Excel)
Nutritional Product, Package Size, and UPC Listing (PDF) | (Excel)
Alberta Blue Cross® Guide to Step Therapy
Alberta Blue Cross® Standard Maximum Allowable Cost (MAC) Drugs and Reference Price Listing
ASEBP TARP Drugs and Reference Price Listing
ASEBP member FAQs regarding TARP policy
Frequent Dispensing Policy Q&As
Maintenance Medication Program Drug Listing
Pharmacist Prescriber Special Authorization Registration Form
Healthcare Professionals Guide – May 1, 2021
Patient Information Sheet – September 29, 2021
Patient Supports – August 30, 2021
Addition of insulin aspart biosimilar – all adult patients on NovoRapid must switch by April 1, 2022 – September 29, 2021
Addition of insulin lispro biosimilar – all adult patients on Humalog must switch by February 1, 2022 – August 1, 2021
Addition of enoxaparin biosimilars – all adult patients on Lovenox must switch by January 10, 2022 – June 1, 2021
Addition of adalimumab biosimilars – all adult patients on Humira must switch by May 1, 2022 – May 1, 2021
Addition of etanercept biosimilar for the indication of plaque psoriasis – November 2, 2020
Physician reminder biosimilars initiative – October 7, 2020
Addition of rituximab and pegfilgrastim biosimilars – September 1, 2020
New information – switch deadline extended to January 15, 2021